This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2024 Zacks Investment Research | 10 S Riverside Plaza Suite #1600 | Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.68% per year. These returns cover a period from January 1, 1988 through August 5, 2024. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View All Zacks #1 Ranked Stocks
Zacks News
Can Fred's Strategies Help It Counter Slow Comps & Traffic?
by Zacks Equity Research
Fred's (FRED) has been struggling with declining store traffic and sluggish comps over the past few quarters. The company has been focusing on cost reduction and internal restructuring.
Rite Aid (RAD) to Report Q2 Earnings: What's in the Cards?
by Zacks Equity Research
Rite Aid Corporation (RAD) is slated to report second-quarter fiscal 2018 results on Sep 28.
Rite Aid Gets FTC Nod for Sale of Fewer Stores to Walgreens
by Zacks Equity Research
After four amendments, Rite Aid Corp. (RAD) and Walgreens Boots Alliance Inc. (WBA) finally received a nod for the fresh proposal the latter put forward yesterday.
Why Did Rite Aid (RAD) Stock Crash Today?
by Ryan McQueeney
Shares of Rite Aid (RAD) fell more than 10% on Tuesday after Walgreens Boots (WBA) received government approval to buy fewer Rite Aid stores than had initially been proposed.
Walgreens to Revisit Rite Aid Deal for Antitrust Approval
by Zacks Equity Research
The Federal Trade Commission ("FTC") seems to be getting harsher on drugstore chains Walgreens Boots Alliance Inc. (WBA) and Rite Aid Corp. (RAD), which have been trying to appease the regulatory body since its initial merger pact in 2015.
Can Bed Bath & Beyond (BBBY) Pull an Earnings Surprise in Q2?
by Zacks Equity Research
Bed Bath & Beyond Inc. (BBBY) is slated to release second-quarter fiscal 2017 results on Sep 19.
Walgreens Boots to Gain From Altered Rite Aid Deal, Alliance
by Zacks Equity Research
The new acquisition deal with Rite Aid would enable Walgreens (WBA) to buy nearly half of its business at a deal value, almost one-third of the original price. Downsides remain a challenge.
What You Should Know About Fred's Apart From Dismal Comps
by Zacks Equity Research
Fred's (FRED) is yet to recover from the cancelled Walgreens-Rite Aid merger. The company has also been struggling with declining sales owing to lower comps and store closures.
5 Stocks to Avoid at all Costs
by David Bartosiak
Here are five strong sell stocks trading at 52-week lows
Unilever, Rite Aid and Facebook highlighted as Zacks Bull and Bear of the Day
by Zacks Equity Research
Unilever, Rite Aid and Facebook highlighted as Zacks Bull and Bear of the Day
Bear of the Day: Rite Aid (RAD)
by Neena Mishra
Dismal results and termination of merger plan sent the stock tumbling.
Rite Aid Seems the Forbidden Fruit, Stock Down 20% in July
by Zacks Equity Research
Ever since Rite Aid Corp.'s (RAD) merger deal with Walgreens Boots Alliance Inc. (WBA) fell through on Jun 29, the stock has turned in to a forbidden fruit for investors.
Fred's Posts Dismal Comparable June Store Sales, Stock Down
by Zacks Equity Research
Fred's, (FRED), which has been struggling to recover from the blow of a failed merger between Rite Aid Corporation (RAD) and Walgreens Boots Alliance (WBA), recently announced soft June comparable store sales.
Rite Aid (RAD) Tanks on Merger Fallout: New Deal Bodes Well?
by Zacks Equity Research
Rite Aid (RAD) saw its shares plummet as its long-awaited acquisition by Walgreens was terminated.
Company News for June 30, 2017
by Zacks Equity Research
Companies in the News are: RAD,WBA,PIR,STZ,AYI
Fred's Stock Falls, Walgreens & Rite Aid Merger Deal Revised
by Zacks Equity Research
Fred's, Inc. (FRED) or Fred's Pharmacy lost over 20% yesterday after Walgreens Boots Alliance, Inc. (WBA) decided not to proceed with its planned takeover of the rival drugstore Rite Aid Corporation (RAD) due to various antitrust issues, as per Bloomberg. The cancelled merger significantly hurt Rite Aid???s stock too, which fell 26.46% yesterday.
Walgreens, Rite Aid Ditch Long-Suffering Drugstore Merger
by Madeleine Johnson
On Thursday, Walgreens Boots Alliance (WBA) announced that it has abandoned efforts to merge with fellow drugstore chain Rite Aid (RAD). Instead, Walgreens will purchase almost half if its rivals stores in a new deal.
Have You Noticed Potential in Herbalife? Stock Adds 48% YTD
by Zacks Equity Research
Shares of Herbalife (HLF) have exhibited a bullish run on the index.
What Will Rite Aid-Walgreens Merger Mean to Fred's (FRED)?
by Zacks Equity Research
Shares of Fred's (FRED) rallied nearly 23% on Jun 26 on rumors about the FTC approval of the acquisition of Rite Aid by Walgreens.
Rite Aid & Fred's Surge on Rumors of Possible Nod for Merger
by Zacks Equity Research
The stocks zoomed on speculations that the long-delayed merger between Rite Aid Corporation (RAD) and Walgreens Boots Alliance Inc. (WBA) could finally see the light of day.
Rite Aid (RAD) Expands with Store Reopening at Harrisburg, PA
by Zacks Equity Research
Consistent with its efforts to expand clinical services and remodeling the concept of wellness stores, Rite Aid Corporation (RAD) recently announced the grand reopening of the Harrisburg Market Street store.
Options Traders Expect Huge Moves in Rite Aid (RDA) Stock
by Zacks Equity Research
Rite Aid (RDA) needs Investors to pay close attention to the stock based on moves in the options market lately.
Fred's (FRED) to Get Additional Funds for Rite Aid Stores
by Zacks Equity Research
Fred's, Inc. (FRED) or Fred's Pharmacy has entered into a second amended and restated commitment letter with a number of banks on Jun 9, 2017.
Why Should You Dump Fred's (FRED) from Your Portfolio Now?
by Zacks Equity Research
Fred's, Inc. (FRED) or Fred's Pharmacy has been disappointing investors of late. Shares of this discount retailer have lost 25.0% over the past three months.
Fred's (FRED) Q1 Loss In Line, Sales Weaker than Expected
by Zacks Equity Research
Fred's, Inc. (FRED) or Fred's Pharmacy posted weaker-than-expected sales in the first quarter of fiscal 2017, while losses were in line with the Zacks Consensus Estimate. The company's share price slumped 11.99% after market closing on Jun 6, 2017.